Codex Revenue and Competitors
Estimated Revenue & Valuation
- Codex's estimated annual revenue is currently $9.9M per year.
- Codex's estimated revenue per employee is $42,489
- Codex's total funding is $4.5M.
- Codex's current valuation is $221M. (January 2022)
Employee Data
- Codex has 233 Employees.
- Codex grew their employee count by 56% last year.
Codex's People
Name | Title | Email/Phone |
---|---|---|
1 | VP Cyber Security | Reveal Email/Phone |
2 | Regional Sales Director | Reveal Email/Phone |
3 | Manager - Instrument Manufacturing | Reveal Email/Phone |
4 | Scientist- Automated Biological Workflows | Reveal Email/Phone |
5 | Business Development Manager | Reveal Email/Phone |
6 | Senior Software Engineer | Reveal Email/Phone |
7 | Quality Control Associate | Reveal Email/Phone |
Codex Competitors & AlternativesAdd Company
Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
---|---|---|---|---|---|
#1 | $2.2M | 27 | 42% | N/A | N/A |
#2 | $9.9M | 233 | 56% | $4.5M | $221M |
#3 | $3.5M | 30 | -3% | N/A | N/A |
What Is Codex?
At Codex, we are committed to leveraging our unique and propriety DNA technologies into scientific solutions for accelerating and advancing research. Our ever-expanding suite of reagents and instrumentation systems are fueling novel and groundbreaking approaches for basic synthetic biology research, as well as biomedical and industrial applications. We?re converting our scientific breakthroughs into innovative products for scientists worldwide for the advancement of scientific research and drug discovery.
keywords:N/A$4.5M
Total Funding
233
Number of Employees
$9.9M
Revenue (est)
56%
Employee Growth %
$221M
Valuation
N/A
Accelerator
Codex News
The Codex Manesse is a richly illustrated work from the first half of the 14th century that brings together many poetic compositions of the...
The Codex Manesse is a richly illustrated work from the first half of the 14th century that brings together many poetic compositions of the...
The Codex Manesse is a richly illustrated work from the first half of the 14th century that brings together many poetic compositions of the...
SAN DIEGO, April 27, 2022 (GLOBE NEWSWIRE) -- Codex DNA, Inc. (Nasdaq: DNAY), a pioneer in automated benchtop synthetic biology systems,...
Codex DNA, Inc. BioXp system and RapidAMP cell-free DNA kit allow scientists to synthesize, clone, and amplify antibody-variable regions based...
Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
---|---|---|---|---|
#1 | $84.1M | 233 | 13% | N/A |
#2 | $3.5M | 233 | 29% | N/A |
#3 | $5.7M | 234 | 31% | $791.4M |
#4 | $45M | 234 | 14% | N/A |
#5 | N/A | 234 | 0% | N/A |